Question 1

What is the catalog number for anti-MCM4?

Accepted Answer

The catalog number for anti-MCM4 is YF-PA24131.

Question 2

What sizes are available for anti-MCM4?

Accepted Answer

anti-MCM4 is available in the following size(s): 50 ul.

Question 3

Is anti-MCM4 in stock?

Accepted Answer

anti-MCM4 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 5

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

anti-MCM4

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Rat Monoclonal 4-1BB/TNFRSF9/CD137 Antibody (LOB12) [Alexa Fluor 532]

IP-10 (Cxcl10, C-X-C Motif Chemokine 10, 10kD Interferon gamma-induced Protein, Gamma-IP10, Interferon-inducible Protein 10, Protein Mob-1, Small-inducible Cytokine B10, Inp10, Mob1, Scyb10) (Biotin) discontinued

BMF protein (T7 tag)

OCRL Polyclonal Antibody

CYP2R1 CRISPRa sgRNA lentivector (set of three targets)(Mouse)

PI 4 Kinase Type 2 beta, NT (Phosphatidylinositol 4-kinase Type 2 beta, PI4K2B, PIK42B, Phosphatidylinositol 4-kinase Type II-beta, PI4KII-beta, PI4KIIB, FLJ11105) (MaxLight 750) discontinued